IL-1 produced and released endogenously within human islets inhibits β cell function

Journal of Clinical Investigation

Volumn 102, Issue 3, 1998, Pages 516-526

  Arnush, Marc ^a   Heitmeier, Monique R ^a   Scarim, Anna L ^a   Marino, Margaret H ^b   Manning, Pamela T ^b   Corbett, John A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

Human islets; Inducible nitric oxide synthase; Insulin dependent diabetes mellitus; Interleukin 1; Macrophages

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MACROPHAGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032146564     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI844     Document Type: Article

References (34)

1. Lacy, P.E. 1994. The intraislet macrophage and type I diabetes. Mount Sinai J. Med. 61:170-174.
2. Schreiner, G.F., W. Fly, E. Brunt, K. Korber, and J.B. Lefkowith. 1988. Essential fatty acid depletion of renal allografts and prevention of rejection. Science. 240:1032-1033.
3. Wright, J.R., J.B. Lefkowith, G. Schreiner, and P.E. Lacy. 1988. Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice. Proc. Natl. Acad. Sci. USA. 85:6137-6141.
4. Lefkowith, J.B., G. Schreiner, J. Cormier, E.S. Handler, H.K. Driscoll, D. Greiner, J.P. Mordes, and A.A. Rossini. 1990. Prevention of diabetes in the BB rat by essential fatty acid-deficiency. Relationship between physiological and biochemical changes. J. Exp. Med. 171:729-743.
5. Oschilewski, U., U. Kiesel, and H. Kolb. 1985. Administration of silica prevents diabetes in BB rats. Diabetes. 34:197-199.
6. Lacy, P.E., and E.H. Finke. 1991. Activation of intraislet lymphoid cells causes destruction of islet cells. Am. J. Pathol. 138:1183-1190.
7. Corbett, J.A., and M.L. McDaniel. 1995. Intraislet release of IL-1 inhibits β cell function by inducing β cell expression of iNOS. J. Exp. Med. 181:559-568.
8. Corbett, J.A., G. Kwon, M. Marino, C.P. Rodi, P.M. Sullivan, and M.L. McDaniel. 1996. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets of Langerhans. Am. J. Physiol. 39: C1581-C1587.
9. Corbett, J.A., M.A. Sweetland, J.L. Wang, J.R. Lancaster, Jr., and M.L. McDaniel. 1993. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA. 90:1731-1735.
10. Ono, J., R. Takaki, and M. Fukuma. 1977. Preparation of single cells from pancreatic islets of adult rat by the use of dispase. Endocrinol. Jpn. 24: 265-270.
11. 15N] nitrate in biological fluids. Anal. Biochem. 126:131-138.
12. Kennedy, M.K., D.S. Torrance, K.S. Picha, and K.M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA correlates with recovery. J. Immunol. 149:2496-2505.
13. Rabinovitch, A., W.L. Saurez-Pinzon, O. Sorensen, R.C. Bleackley, and R.F. Power. 1995. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:4874-1882.
14. Eizirik, D.L., S. Sandler, N. Welsh, M. Cetkovic-Cvrlje, A. Nieman, D.A. Geller, D.G. Pipeleers, K. Bendtzen, and C. Hellerstrom. 1994. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 93:1968-1974.
15. Corbett, J.A., R.G. Tilton, K. Chang, K.S. Hasan, Y. Ido, J.L. Wang, M.A. Sweetland, J.R. Lancaster, Jr., J.R. Williamson, and M.L. McDaniel. 1991. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:552-556.
16. Misko, T.P., W.M. Moore, T.P. Kasten, G.A. Nickols, J.A. Corbett, R.G. Tilton, M.L. McDaniel, J.R. Williamson, and M.G. Currie. 1993. Selective inhibition of the inducible isoform of nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:119-125.
17. Rabinovitch, A., W.L. Saurez-Pinzon, O. Sorensen, and R.C. Bleackley. 1996. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice. Identification of iNOS expression cells and relationship to cytokines expressed in the islets. Endocrinology. 137:2093-2099.
18. Cailleau, C., A. Diu-Hercend, E. Ruuth, R. Westwood, and C. Carnaud. 1997. Treatment with neutralizing antibodies specific for IL-1β prevents cyclophosphamide-induced diabetes in nonobese diabetic mice. Diabetes. 46:937-940.
19. Hill, J.R., J.A. Corbett, G. Kwon, C.A. Marshall, and M.L. McDaniel. 1996. Nitric oxide regulates interleukin-1 bioactivity released from murine macrophages. J. Biol. Chem. 271:22672-22678.
20. Hogquist, K.A., M.A. Nett, E.R. Unanue, and D.D. Chaplin. 1991. Interleukin-1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA. 88:8485-8489.
21. Zychlinsky, A., C. Fitting, J.M. Cavaillon, and P.J. Sansonetti. 1994. Interleukin-1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J. Clin. Invest. 94:1328-1332.
22. Heitmeier, M.R., A.L. Scarim, and J.A. Corbett. 1997. IFN-γ increases the sensitivity of islets of Langerhans for iNOS expression induced by IL-1. J. Biol. Chem. 272:13653-13661.
23. Nicholson, S., M.G. Bonecini-Almeida, L.E. Silva, Jr., C. Nathan, Q.-W. Xie, R. Mumford, J.R. Weidner, J. Calaycay, J. Geng, N. Boechat, et al. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293-2302.
24. Guo, F.H., H.R. DeRaeve, T.W. Rice, D.J. Stuehr, F.B. Thunnissen, and S.C. Erzurum. 1995. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. USA. 92:7809-7813.
25. Watkins, S.C., W. Macaulay, D. Turner, R. Kang, H.E. Rubash, and C.H. Evans. 1997. Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses. Am. J. Pathol. 150:1199-1206.
26. Albina, J.E. 1995. On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukocyte Biol. 58:643-649.
27. Benoist, C. and D. Mathis. 1997. Cell death mediators in autoimmune diabetes. No shortage of suspects. Cell. 89:1-3.
28. Barnett, A.H., C. Eff, R.D. Leslie, and D.A. Pyke. 1981. Diabetes in identical twins: a study of 200 pairs. Diabetologia. 20:87-93.
29. Bach, J.-F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrinol. Rev. 15:516-541.
30. Yoon, J.W. 1991. Role of viruses in the pathogenesis of IDDM. Ann. Med. 23:437-445.
31. Nerup, J., and A. Lernmark. 1981. Autoimmunity in insulin-dependent diabetes mellitus. Am. J. Med. 70:135-141.
32. Peschke, T., A. Bender, M. Nain, and D. Gemsa. 1993. Role of macrophage cytokines in influenza A virus infections. Immunobiology. 189:340-355.
33. Henke, A., C. Mohr, C. Graebner, A. Stelzner, M. Nain, and D. Gernsa. 1992. Coxsackie virus B3-induced production of tumor necrosis factor-alpha. IL-1 beta and IL-6 in human monocytes. J. Immunol. 148:2270-2277.
34. Heitmeier, M.A., A.L. Scarim, and J.A. Corbett. 1998. Double-stranded RNA-induced iNOS expression and IL-1 release by murine macrophages requires NF-kB activation. J. Biol. Chem. 273:15301-15307.